mTOR

All prioritized active compounds showed good affinity for MTOR. Combined inhibition of IGF-1R and mTOR has been reported to triple response rates compared with IGF-1R inhibition alone. MTOR is the most prominent docking-supported target in the study. The study identifies MTOR as the leading target from docking while retaining other network-supported targets. mTOR is described as a growth-promoting signaling complex found in many tissues. The article argues that mTOR activation should be interpreted by tissue context rather than treated as uniformly harmful. Methionine restriction is presented as potentially relevant in specialized contexts but not as a general reason for aging adults to chronically restrict high-quality protein. HIS875 was a shared interacting residue across prioritized compounds in MTOR docking. Leucine and essential amino acids stimulate skeletal muscle mTOR as part of muscle protein synthesis. MTOR was identified as one of five central targets by network pharmacology analysis. mTOR is part of the downstream oncogenic signaling activated by IGF-1R. The reported benefit of IGF-1R and mTOR co-inhibition supports the idea that feedback structures can be made more f…